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Introduction {#sec1}
============

Posttranslational modifications in the tail region of core histones are important epigenetic marks linked to various nuclear functions, including transcriptional activity control. The discovery of enzymes that add/remove methyl groups to/from histones suggests that histone methylation levels are not statically but dynamically controlled ([@bib10]). So far, individual functions of histone methyltransferases or demethylases have been studied extensively, but the role sharing between methyltransferases and demethylases for the correct establishment of histone methylated epigenome is not yet fully understood.

Histone H3 lysine 9 (H3K9) methylation is considered as an epigenetic mark of transcriptionally silenced heterochromatin. The JMJD1 family of proteins, which includes JMJD1A and its isozyme JMJD1B, reportedly possesses intrinsic H3K9 demethylating activity ([@bib8], [@bib11], [@bib22]). JMJD1A plays important roles in several biological processes such as spermiogenesis ([@bib14], [@bib16]), metabolism ([@bib7], [@bib20]), and sex determination ([@bib12]). Recently, JMJD1B was shown to be required for female fertility ([@bib13]). In contrast to the individual function of JMJD1A and JMJD1B in postnatal mice, the role of JMJD1 proteins in early embryogenesis and their functional redundancy are still unknown.

In this study, we demonstrated that JMJD1A and JMJD1B are redundantly but essentially required for mouse development immediately after implantation. We also demonstrated that JMJD1A and JMJD1B exhibit pivotal roles in mouse embryonic stem cell (ESC) function through the correct establishment of H3K9 methylated epigenome. Not a single depletion but depletion of both JMJD1A and JMJD1B induced a massive increase in H3K9 methylation accompanied by rapid cell death and perturbed gene expression. In control ESCs, dimethylated H3K9 (H3K9me2) was abundant in the gene-poor regions and scarce in the gene-dense regions of the chromosomes. Intriguingly, JMJD1A/JMJD1B deficiency induced a remarkable increase of H3K9me2 in the gene-dense regions, causing aberrant H3K9me2 distribution; high levels of H3K9me2 decorate chromosomes throughout. This result implies that JMJD1A/JMJD1B preferentially target H3K9 demethylation at the gene-dense euchromatin. Finally, we found that the additional mutation for an H3K9 methyltransferase G9A in a JMJD1A/JMJD1B-deficient background restored not only H3K9 overmethylation but also rapid cell death and perturbed gene expression phenotypes, indicating collaborative roles of JMJD1A/JMJD1B and G9A not only for the tuning of the H3K9 methylation levels but also for the regulation of ESC function. Taking these results together, we propose that JMJD1A/JMJD1B ensures cellular viability and transcription accuracy through the establishment of the correct H3K9 methylated epigenome in early mouse development.

Results {#sec2}
=======

JMJD1A and JMJD1B Are Essentially Required for Peri-implantation Development in Mice {#sec2.1}
------------------------------------------------------------------------------------

Previous studies had demonstrated that JMJD1A and JMJD1B possess intrinsic H3K9 demethylating activity ([@bib8], [@bib11], [@bib22]), suggesting that JMJD1A and JMJD1B may function in a redundant manner. To evaluate the roles of JMJD1A and JMJD1B in peri-implantation development, we examined the expression profiles of JMJD1A and JMJD1B in developing embryos ([Figure 1](#fig1){ref-type="fig"}A). Immunofluorescence analysis with anti-JMJD1A antibodies revealed that JMJD1A is expressed in the epiblast and extraembryonic ectoderm at embryonic day (E) 6.5 ([Figure 1](#fig1){ref-type="fig"}A, left). To detect the endogenous JMJD1B protein with an anti-FLAG tag antibody, we established knockin mouse and ESC lines carrying modified *Jmjd1b* allele (referred as *1b* hereafter). In the resultant lines, *1b*^+/Flag−KI^ allele produces the JMJD1B protein with a carboxy-terminal FLAG tag ([Figure S1](#mmc1){ref-type="supplementary-material"}). Immunofluorescence analysis of *1b*^+/Flag−KI^ embryos with anti-FLAG tag antibody revealed that JMJD1B is expressed in the epiblast, extraembryonic ectoderm, and ectoplacental cone of E6.5 embryos ([Figure 1](#fig1){ref-type="fig"}A, right). We measured and plotted the signal intensities for JMJD1 proteins in the embryonic lineages ([Figure 1](#fig1){ref-type="fig"}A, plot analyses). Consequently, JMJD1A and JMJD1B were both found to be abundantly expressed in the epiblast of the developing embryos, indicating the potential roles of JMJD1A and JMJD1B in epiblast development.Figure 1JMJD1A and JMJD1B Are Essential for Mouse Embryogenesis(A) Immunofluorescence analysis of longitudinal sections of the E6.5 embryos with JMJD1A (left) and JMJD1B (right). E6.5 wild-type embryos were stained with anti-JMJD1A antibodies and DAPI (left). E6.5 *Jmjd1b*^+/Flag−KI^ embryos were stained with anti-FLAG antibodies and DAPI (right). Fluorescence intensities along the dashed lines were quantified and plotted on the right side of the images. Scale bars, 100 μm. Epi, epiblast; EXC, extraembryonic ectoderm; EPC, ectoplacental cone; Dc, decidual cells. A.U., arbitrary unit.(B) *Jmjd1a*^+/Δ^; *Jmjd1a*^+/Δ^ males and females were crossed, and the resultant embryos were genotyped at the indicated embryonic periods. *Jmjd1a*^Δ/Δ^; *Jmjd1a*^Δ/Δ^ embryos were found at E6.5, but not at E7.5. \#, growth-retarded embryos.(C) Gross appearances of *Jmjd1a*/*Jmjd1b* double-deficient embryos at E6.5 (left) when compared with a littermate control (right). *1a* and *1b* represent *Jmjd1a* and *Jmjd1b*, respectively. Scale bar, 100 μm.(D) Whole-mount immunostaining analysis for the epiblast marker OCT3/4. Embryos were counterstained with DAPI and TUNEL to detect apoptotic cells. Scale bars, 100 μm.(E) TUNEL-positive cells in the epiblast lineage were counted and summarized. *Jmjd1a*^+/Δ^; *Jmjd1a*^+/Δ^, n = 7; *Jmjd1a*^Δ/Δ^; *Jmjd1a*^Δ/Δ^, n = 3 different embryos (biological replicates). Data are presented as means ± SD. ^∗∗^p \< 0.01 (Student\'s t test).

We established mutant mice bearing the *1b*^Δ^ allele, which lacks exons 20--21, corresponding with a portion of the catalytic JmjC domain ([Figure S1](#mmc1){ref-type="supplementary-material"}). The *1b*^Δ/Δ^ mice were born at nearly the expected Mendelian ratio, but most of them died within a week after birth ([Figure S2](#mmc1){ref-type="supplementary-material"}). Some of the *1b*^Δ/Δ^ mice survived and developed into adults; however, their body weights were almost half those of the controls ([Figure S2](#mmc1){ref-type="supplementary-material"}). These phenotypes are in accordance with those reported in a recent study ([@bib13]). To evaluate the effects of compound depletion of JMJD1A and JMJD1B on mouse development, we examined postnatal animals and embryos derived from the mating of *1a*/*1b* double-heterozygous mutant mice. Among the 109 neonatal offspring, no JMJD1A/JMJD1B-deficient mice were found, strongly suggesting that JMJD1A/JMJD1B-deficient mice were embryonically lethal ([Figure S2](#mmc1){ref-type="supplementary-material"}). Intriguingly, all of the mice carrying three mutant alleles of *1a* or *1b* were stillborn, indicating that the gene dosage of *1a*/*1b* is critical for prenatal development ([Figure S2](#mmc1){ref-type="supplementary-material"}). Embryos bearing the *1a*/*1b* double-homozygous mutation were not found in 70 embryos at E7.5, whereas three embryos with this mutation were found in 78 embryos at E6.5 ([Figure 1](#fig1){ref-type="fig"}B). Notably, all JMJD1A/JMJD1B-deficient embryos were smaller than the controls at this stage ([Figure 1](#fig1){ref-type="fig"}C). These data suggest that JMJD1A/JMJD1B-deficient embryos display growth retardation and die around E6.5.

To examine the development of JMJD1A/JMJD1B-deficient embryos in more detail, we performed a whole-mount immunostaining analysis using antibodies against OCT3/4, which mark epiblast cells ([Figure 1](#fig1){ref-type="fig"}D). Apoptotic cells were detected by TUNEL labeling ([Figure 1](#fig1){ref-type="fig"}D). Strikingly, the mass size of OCT3/4-positive epiblasts in JMJD1A/JMJD1B-deficient embryos was smaller than those in the control embryos ([Figure 1](#fig1){ref-type="fig"}D, middle panels). We also found some JMJD1A/JMJD1B-deficient embryos without detectable epiblast cells ([Figure 1](#fig1){ref-type="fig"}D, right panels). TUNEL counterstaining analysis demonstrated a significant increase in the number of apoptotic cells in the epiblasts of JMJD1A/JMJD1B-deficient embryos (summarized in [Figure 1](#fig1){ref-type="fig"}E). These data indicate that growth retardation of JMJD1A/JMJD1B-deficient embryos can be attributed, in part, to the compromised development of the epiblast cells. We therefore conclude that JMJD1A and JMJD1B play redundant but essential roles for post-implantation development in mouse.

JMJD1A and JMJD1B Are Essentially Required for ESC Viability {#sec2.2}
------------------------------------------------------------

To further address the roles of JMJD1-mediated H3K9 demethylation in early embryogenesis, we used mouse ESCs, which provide a good tool for studying the developmental process of pre- and post-implantation embryos. Immunoblot analysis indicated that JMJD1A and JMJD1B were both expressed in ESCs ([Figure 2](#fig2){ref-type="fig"}). We previously generated ESCs lacking JMJD1A by a simple targeting method ([@bib7]). Also, we have established ESCs lacking JMJD1B in this study ([Figure S1](#mmc1){ref-type="supplementary-material"}), indicating that neither JMJD1A nor JMJD1B is essential for ESC survival. To address the impact of JMJD1A and JMJD1B double-deficiencies in ESC function, we tried to establish an ESC line with conditionally depleted JMJD1 proteins. The conditional targeting vector of *Jmjd1b* was constructed and then introduced into the JMJD1A-deficient ESC line ([Figure S1](#mmc1){ref-type="supplementary-material"}). To convert functional *1b*^2lox^ alleles into defective *1b*^1lox^ alleles in a 4-hydroxy tamoxifen (4OHT)-dependent manner, the MerCreMer (Cre flanked by mutated estrogen receptor ligand-binding domains) expression plasmid was also introduced into the homologous recombinant lines. We consequently obtained *1a*/*1b*-conditional knockout (KO) lines named Quad-cKO (*Jmjd1a*^Δ/Δ^; *Jmjd1b*^2lox1FRT/2lox2FRT^; *Mer-Cre-Mer*) ([Figure 2](#fig2){ref-type="fig"}A). Quad-cKO cell lines were cultured with 4OHT and then applied to immunoblot analysis ([Figures 2](#fig2){ref-type="fig"}B and 2C). Time-course experiments showed that JMJD1B signal disappeared after the 4OHT treatment for 2 days ([Figure 2](#fig2){ref-type="fig"}B). We confirmed the absence of JMJD1A signals, as well as JMJD1B signals, in the 4OHT-treated Quad-cKO cells ([Figure 2](#fig2){ref-type="fig"}C). We, thus, successfully generated ESC lines with conditionally depleted JMJD1 proteins.Figure 2Depletion of JMJD1A and JMJD1B Induces Growth Arrest in ESCs(A) List of the established ESC lines and their genotypes. MerCreMer, Cre flanked by mutated estrogen receptor ligand-binding domains.(B) Time-course analysis of 4OHT-dependent depletion of JMJD1B in Quad-cKO cells.(C) Immunoblot analyses of JMJD1A/JMJD1B-depleted ESC lines. Whole extracts of the indicated ESC lines were fractionated using SDS-PAGE and then applied to immunoblot analysis with antibodies against JMJD1A and JMJD1B. JMJD1A and JMJD1B were depleted in the Quad-cKO cell lines cultured with 800 nM 4OHT for 4 days. Asterisk (^∗^) represents non-specific signals.(D) The indicated ESC lines were cultured in the presence or absence of 4OHT. Cell numbers were determined every 2 days. Growth arrest became apparent when the Quad-cKO cell line was cultured in the presence of 4OHT for 4 days (right). In contrast, wild-type (left) and Tetra-cKO (middle) cells grew in the presence of OHT.(E) Time-course analysis of JMJD1 depletion-induced cell death. The indicated ESC lines were cultured in the presence of 4OHT, following which the cells were stained with PI and annexin V and analyzed using flow cytometry.(F) Expression levels of pluripotency-associated (left) and lineage-associated (right) genes in Quad-cKO cells treated with 4OHT were examined using RT-qPCR. We used *Fgf5*, *Gata4*, and *Brachyury* as the markers for primitive ectoderm, endoderm, and mesoderm, respectively. Representative data are presented from independent triplicate experiments. Error bars indicate means ± SD derived from technical replicates.(G and H) Rescue of the growth arrest phenotype by exogenous introduction of JMJD1B into Quad-cKO cell line. (G) Expression vectors for FLAG-tagged wild-type JMJD1B or enzymatically inactive H1561A mutants of JMJD1B were individually and stably introduced into the Quad-cKO cell line. The expression levels of exogenously expressed proteins were compared by immunoblot analysis. (H) Comparison of protein expression levels of endogenously expressed JMJD1B and exogenously expressed JMJD1B using anti-JMJD1B antibody. JMJD1B expression levels were compared between wild-type ESCs and 4OHT-treated Quad-cKO cells expressing FLAG-JMJD1B-WT.(I) Quad-cKO cell lines expressing wild-type JMJD1B (left) or the enzymatically inactive H1561A mutant of JMJD1B (right) were cultured in the presence of 4OHT. Exogenous expression of wild-type JMJD1B rescued the growth arrest phenotype of Quad-cKO cells in the presence of 4OHT, whereas the enzymatically inactive H1561A mutant did not.

Next, we examined the growth potential of Quad-cKO cell lines. Tetra-cKO (*Jmjd1a*^Δ/Δ^; *Jmjd1b*^+/2lox2FRT^; *Mer-Cre-Mer*) cells that carried two disrupted *Jmjd1a* alleles and single conditional allele of *Jmjd1b* were generated as controls ([Figure 2](#fig2){ref-type="fig"}A). The parental wild-type cells (TT2 line) and Tetra-cKO cells could grow exponentially in the presence of 4OHT ([Figure 2](#fig2){ref-type="fig"}D, left and middle panels, respectively). In contrast, when Quad-cKO cell lines were cultured in the presence of 4OHT, an increase in cell numbers was noted during the first 2 days, which was followed by a decrease in number ([Figure 2](#fig2){ref-type="fig"}D, right panel). Note that we could not establish cell lines lacking both JMJD1A and JMJD1B due to severe growth defect in the Quad-cKO cell lines when the two proteins were depleted. Taking these results together, we concluded that JMJD1A and JMJD1B are redundantly but essentially required for ESC survival.

To examine the cause of growth arrest in ESCs lacking JMJD1A and JMJD1B, we assessed the cell viability by staining with propidium iodide (PI) and annexin V ([Figure 2](#fig2){ref-type="fig"}E). The number of early apoptotic cells that stained positively with annexin V and negatively with PI increased when the Quad-cKO cell line was cultured in the presence of 4OHT for 2 days; remarkably, the number further increased with 4OHT treatment for another 2 days ([Figure 2](#fig2){ref-type="fig"}E, bottom panel). In addition, the number of dead cells that stained positively with both annexin V and PI simultaneously increased ([Figure 2](#fig2){ref-type="fig"}E, bottom panel). The progressive increase in the number of apoptotic cells might account for the growth defect of ESCs lacking JMJD1A and JMJD1B, at least in part. In contrast, 4OHT treatment had a moderate effect on the number of apoptotic and dead cells in the Tetra-cKO cell line ([Figure 2](#fig2){ref-type="fig"}E, top panel). We also conducted cell cycle analysis of Quad-cKO cells by measuring bromodeoxyuridine (BrdU) incorporation and the DNA contents ([Figure S3](#mmc1){ref-type="supplementary-material"}). 4OHT treatment did not have a profound effect on cell cycle progression in both Quad-cKO and Tetra-cKO cell lines. Therefore, the growth defect phenotype in JMJD1A/JMJD1B-depleted ESCs partly results from an increase in the apoptotic cell death.

To investigate how JMJD1A/JMJD1B depletion influenced the pluripotency of ESCs, we examined mRNA expression levels of six pluripotency-associated genes (*Oct3/4*, *Nanog*, *Sox2*, *Klf2*, *Klf4*, and *Tcl1*) and three lineage-associated genes (*Fgf5*, *Gata4*, and *Brachyury*) in 4OHT-treated Quad-cKO cells ([Figure 2](#fig2){ref-type="fig"}F). The expression of four pluripotency-associated genes, *Oct3/4*, *Nanog*, *Klf4*, and *Tcl1*, was downregulated ([Figure 2](#fig2){ref-type="fig"}F, left), whereas that of the lineage-associated primitive endoderm marker gene *Fgf5* was upregulated in 4OHT-treated Quad-cKO cells ([Figure 2](#fig2){ref-type="fig"}F, right). These results indicate that JMJD1A/JMJD1B depletion in ESCs might compromise the self-renewal property of pluripotent ESCs and/or prompt their differentiation.

It is important to elucidate whether the growth arrest of JMJD1A/JMJD1B-depleted cells was dependent on JMJD1-mediated enzymatic activity. To address this issue, we performed rescue experiments using *Jmjd1b* expression vectors. Expression vectors for FLAG-tagged wild-type JMJD1B and catalytically defective JMJD1B^H1561A^ ([Figure S3](#mmc1){ref-type="supplementary-material"}) were stably introduced into the Quad-cKO cells ([Figure 2](#fig2){ref-type="fig"}G). We confirmed that the protein expression levels of exogenously introduced JMJD1B were higher than that of endogenous JMJD1B ([Figures 2](#fig2){ref-type="fig"}G and 2H). As shown in [Figure 2](#fig2){ref-type="fig"}I, Quad-cKO cells carrying wild-type *Jmjd1b* transgene had a clearly restored growth potential in the presence of 4OHT. In contrast, the growth potential of Quad-cKO cells carrying *Jmjd1b*^H1561A^ transgene was not restored, even though the expression level of exogenously introduced JMJD1B^H1561A^ was higher than that of wild-type ([Figure 2](#fig2){ref-type="fig"}G). These findings indicate that the H3K9 demethylating activity of JMJD1 enzymes is absolutely required for ESC survival.

JMJD1A and JMJD1B Substantially Contribute to H3K9 Demethylation in ESCs {#sec2.3}
------------------------------------------------------------------------

To address how JMJD1A and JMJD1B contribute to H3K9 methylation status of ESCs, we examined H3K9 methylation levels of mutant ESCs by immunoblot analysis ([Figures 3](#fig3){ref-type="fig"}A--3C). Dimethylated H3K9 (H3K9me2) was markedly increased in the Quad-cKO cell line when cultured in the presence of 4OHT for 2 days onward ([Figure 3](#fig3){ref-type="fig"}A). We next compared the H3K9 methylation levels among wild-type, JMJD1A-deficient, JMJD1B-deficient, and JMJD1A/JMJD1B-depleted ESCs using a panel of specific antibodies by immunoblot analysis ([Figure 3](#fig3){ref-type="fig"}B) ([@bib9]). H3K9me1 levels remained unchanged even after *1a*/*1b* compound mutation (summarized in [Figure 3](#fig3){ref-type="fig"}C, left panel). In contrast, the compound mutation led to robust increases in the levels of H3K9me2 and me3 (summarized in [Figure 3](#fig3){ref-type="fig"}C, middle and right panels, respectively). Single mutations of *1a* or *1b* led to only moderate increases in the levels of H3K9me2 and me3, indicating that JMJD1A and JMJD1B redundantly catalyze H3K9 demethylation in ESCs.Figure 3JMJD1A and JMJD1B Substantially Contribute to H3K9 Demethylation in ESCs(A) Time-course analysis of JMJD1B-depletion-induced increase in H3K9me2 in 4OHT-treated Quad-cKO cells.(B) Immunoblot analyses of H3K9 methylation levels in the indicated ESC lines.(C) The methylation levels of H3K9me1 (left), H3K9me2 (middle), and H3K9me3 (right) in the indicated ESC lines were determined by immunoblot analysis. The intensities of H3K9me signals of wild-type cells were defined as 1. Data are presented as means ± SD (n = 3 independent experiments). ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (Student\'s t test).(D--F) Nuclear distribution profiles of H3K9me1 (D), H3K9me2 (E), and H3K9me3 (F) in JMJD1A/JMJD1B-depleted ESCs compared with those in the wild-type ESCs. Scale bars, 5 μm.

We compared nuclear distribution profiles of H3K9 methylation between wild-type and JMJD1A/JMJD1B-depleted ESCs by immunocytochemistry. Neither distribution nor intensity of H3K9me1 signals was affected by JMJD1A/JMJD1B depletion ([Figure 3](#fig3){ref-type="fig"}D). H3K9me2 signals were detected mostly at the euchromatic regions in wild-type nuclei ([Figure 3](#fig3){ref-type="fig"}E, left panels). Distribution profiles of H3K9me2 signals seemed to be unaffected by JMJD1A/JMJD1B depletion; nevertheless, the signal intensities were dramatically increased ([Figure 3](#fig3){ref-type="fig"}E, right panels). H3K9me3 were detected mainly at the pericentric heterochromatin as dense signals in both wild-type and JMJD1A/JMJD1B-depleted cells ([Figure 3](#fig3){ref-type="fig"}F). Interestingly, we observed that JMJD1A/JMJD1B depletion led to a significant increase in H3K9me3 signals in the euchromatin ([Figure 3](#fig3){ref-type="fig"}F, right panels). These results strongly suggest that the increase in H3K9me2/3 in JMJD1A/JMJD1B-depleted ESCs is attributed to the increase in H3K9me2/3 in the euchromatin.

JMJD1A/JMJD1B-Mediated H3K9 Demethylation Targets Gene-Dense Regions of Chromosomes {#sec2.4}
-----------------------------------------------------------------------------------

The next important question is which loci are targeted by JMJD1A/JMJD1B-mediated H3K9 demethylation in ESCs. To address this issue, we performed chromatin immunoprecipitation (ChIP) analysis using antibodies against H3K9me2. Mononucleosome was prepared by enzymatic digestion of ESC chromatin and then applied to ChIP sequencing (ChIP-seq) analysis ([Figure 4](#fig4){ref-type="fig"}). Importantly, approximately 1.7 times more DNA was immunoprecipitated with anti-H3K9me2 antibody from JMJD1A/JMJD1B-depleted nuclei than from wild-type nuclei, indicating that JMJD1A/JMJD1B depletion resulted in a genome-wide increase in H3K9me2 ([Figure S4](#mmc1){ref-type="supplementary-material"}). The distribution profile of H3K9me2 on chromosome 11 is representatively shown in [Figure 4](#fig4){ref-type="fig"}A; the relatively gene-poor region spans 10--50 M and relatively gene-dense region spans 50--120 M ([Figure 4](#fig4){ref-type="fig"}A, upper panel). H3K9me2 was detected throughout chromosome 11 in wild-type cells, indicating high abundance of the H3K9me2 marks ([Figure 4](#fig4){ref-type="fig"}A, middle panel). It is intriguing that H3K9me2 distributes evenly with high levels of methylation in the gene-poor region, whereas H3K9me2 distributes unevenly with high and low levels of methylation in the gene-dense region of chromosome 11 in wild-type cells. In the gene-dense region, we observed a typical feature between the gene densities and enrichment of H3K9me2 in wild-type ESCs; loci with low gene densities were heavily methylated, while those with high gene densities were hypomethylated ([Figure 4](#fig4){ref-type="fig"}A, middle panel). JMJD1A/JMJD1B depletion resulted in increased levels of H3K9me2 throughout chromosome 11 ([Figure 4](#fig4){ref-type="fig"}A, bottom panel). These characteristics were common in the other chromosomes ([Figure S4](#mmc1){ref-type="supplementary-material"}). Notably, the increase in H3K9me2 levels due to JMJD1A/JMJD1B depletion in the gene-dense region seemed to be higher than that in the gene-poor region. To address this quantitatively, the relationship between the increased H3K9me2 levels due to JMJD1A/JMJD1B depletion and gene densities of all chromosomes was statistically evaluated by calculating the average levels of H3K9me2 in comparison with the gene densities (number of genes per 500 kb genome). As shown in [Figure 4](#fig4){ref-type="fig"}B, there was a positive correlation between the increased H3K9me2 levels due to JMJD1A/JMJD1B depletion and gene densities, implying that JMJD1A/JMJD1B preferentially targets H3K9 demethylation in these regions ([Figure 4](#fig4){ref-type="fig"}B). The distribution profiles of H3K9me2 with narrower windows in the gene-poor and gene-dense regions of chromosome 11 are shown in [Figures 4](#fig4){ref-type="fig"}C and 4D, respectively. In the gene-poor region, H3K9me2 levels of JMJD1A/JMJD1B-depleted cells were approximately one and a half times higher than that of wild-type cells. In contrast, H3K9me2 levels of JMJD1A/JMJD1B-depleted cells were more than three times higher than that of wild-type cells, confirming that JMJD1A/JMJD1B preferentially targets H3K9 demethylation in gene-dense regions ([Figures 4](#fig4){ref-type="fig"}C and 4D).Figure 4JMJD1A/JMJD1B-Mediated H3K9 Demethylation Targets Gene-Dense Euchromatin(A) Distribution profiles of H3K9me2 along chromosome 11. The upper panel shows the number (\#) of mm10 RefSeq genes smoothed with a width of 500 kb. The middle and lower panels represent the ratios of normalized read density between ChIP and whole-cell lysate (input) samples (ChIP/input) in wild-type and JMJD1A/JMJD1B-depleted cells (Quad-cKO+4OHT), respectively. The ratio of ChIP/input \>1.6 is shown in orange.(B) Correlation between gene density and increased H3K9me2 levels due to JMJD1A/JMJD1B depletion. The x and y axes indicate the number of mm10 RefSeq genes and the quotient of ChIP/input of Quad-cKO+4OHT divided by ChIP/input of wild-type (WT), respectively, smoothed with a 500 kb width. The dashed lines represent regression lines.(C and D) Distribution profile of H3K9me2 in a gene-poor region (C), arrow showing the position in (A), or a gene-dense region (D), arrowhead showing the position in (A) within chromosome 11. The upper panels show the positions of the protein-coding genes, whereas lower tracks depict ChIP/input in the indicated samples.

Profound Effect of JMJD1A/JMJD1B Depletion on Gene Expression {#sec2.5}
-------------------------------------------------------------

As the enrichment of H3K9 methylation marks is relevant to transcriptionally silenced heterochromatin, the distorted distribution of H3K9me2 might induce the alteration of gene expression in JMJD1-depleted cells. To address this, we performed a microarray analysis using RNAs from wild-type, JMJD1B-deficient, JMJD1A-deficient (Quad-cKO cell lines), and JMJD1A/JMJD1B-depleted cells (Quad-cKO cell lines cultured in the presence of 4OHT). Hierarchical clustering analysis revealed that each of the genotype-identical sets forms the smallest clusters, indicating that it is not the clonal but the genetic difference that influences gene expression ([Figure 5](#fig5){ref-type="fig"}A). The cluster of JMJD1A/JMJD1B-depleted cells was the farthest from those of the other cells, indicating that compound depletion of JMJD1A and JMJD1B has the most prominent effect on transcription. Based on this notion, the numbers of genes up- or downregulated by JMJD1A/JMJD1B double depletion were found to be larger than the numbers affected by single mutation ([Figure 5](#fig5){ref-type="fig"}B, genes are listed in [Table S2](#mmc2){ref-type="supplementary-material"}).Figure 5Depletion of JMJD1A and JMJD1B Alters Gene Expression Profile in ESCsRNAs were prepared from ESCs and subjected to a microarray analysis using an Affymetrix mouse genome 430 2.0 array.(A) Hierarchical clustering analysis of gene expression profiles in wild-type cells (TT2 lines), JMJD1A-deficient cells (Quad-cKO cell lines), JMJD1B-deficient cells, and JMJD1A/JMJD1B-double-depleted cells (Quad-cKO cell lines cultured with 4OHT). The farthest distance was observed between the cluster of JMJD1A/JMJD1B-double-depleted cells and the other cell clusters, indicating that the compound depletion of JMJD1A and JMJD1B has the most prominent effect on transcription.(B) Numbers of genes affected by the JMJD1A and/or JMJD1B depletion in ESCs. Downregulated genes (\<0.5-fold) and upregulated genes (\>2.0-fold) due to each mutation are represented as dark and white bars, respectively.(C) Comparison of mRNA levels in the 204 genes between the indicated samples, which were downregulated by JMJD1A/JMJD1B double depletion. Heatmap analysis demonstrated that single depletion had a moderate effect on the transcription of these genes compared with double depletion.(D) Quantitative analysis of H3K9me2 levels of the genes regulated by JMJD1A and JMJD1B. Averaged increase in H3K9me2 around the gene bodies down- (blue) and upregulated (red) due to JMJD1A/JMJD1B depletion was plotted. The x axes indicate % gene length; 0% and 100% represent transcription start site and transcription end site, respectively. The y axes indicate the average of the quotient of ChIP/input of Quad-cKO+4OHT divided by ChIP/input of wild-type.(E) H3K9 methylation levels of the promoter regions of *Oct3/4* (left) and *Ccnd1* (right) of the indicated ESCs.(F) mRNA expression levels of *Oct3/4* (left) and *Ccnd1* (right) of the indicated ESCs.(G) ChIP analysis for JMJD1A at the promoter regions of *Oct3/4* (left) and *Ccnd1* (right) with anti-JMJD1A antibodies.(H) ChIP analysis of JMJD1B at the promoter regions of *Oct3/4* (left) and *Ccnd1* (right) using anti-FLAG antibody. To detect endogenous JMJD1B with anti-FLAG antibody, we established knockin ESC line carrying*1b*^+/Flag−KI^ allele, in which the modified *1b* allele produces JMJD1B protein with a FLAG tag at its carboxy terminus ([Figure S1](#mmc1){ref-type="supplementary-material"}).For (E--H), data are presented as means ± SD from n = 3 independent experiments. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (Student\'s t test).

Next, we examined the individual roles of JMJD1A and JMJD1B on the transcriptional regulation of the 204 genes that were downregulated by JMJD1A/JMJD1B double depletion. A heatmap analysis revealed that JMJD1A or JMJD1B deficiency alone had only moderate effects on the downregulation of those genes, indicating that JMJD1A and JMJD1B upregulate these genes in a redundant manner ([Figure 5](#fig5){ref-type="fig"}C). Among the 204 genes, 134 were downregulated only when both JMJD1A and JMJD1B were depleted ([Figure S5](#mmc1){ref-type="supplementary-material"}). Gene ontology (GO) analyses demonstrated that metabolic processes such as one-carbon metabolism and amino acid biosynthesis were significantly enriched among the 134 genes ([Figure S5](#mmc1){ref-type="supplementary-material"}). On the other hand, the genes of many pathways, such as reproductive process, inflammatory pathway, and cellular differentiation, were significantly enriched among the genes upregulated only when both JMJD1A and JMJD1B were depleted ([Figure S5](#mmc1){ref-type="supplementary-material"}). To elucidate the cause of distorted gene expression in JMJD1A/JMJD1B-depleted cells, we examined H3K9 methylation levels in the genomic portion surrounding the down- and upregulated genes ([Figure 5](#fig5){ref-type="fig"}D). We found that JMJD1A/JMJD1B depletion increased H3K9 methylation levels of the downregulated genes more profoundly than those of the upregulated genes ([Figure 5](#fig5){ref-type="fig"}D). Therefore, it is conceivable that these genes are the direct targets of JMJD1A and JMJD1B.

Because previous studies have demonstrated that H3K9 methylation negatively controls the transcription of genes including *Oct3/4* ([@bib3]) and a D-type cyclin *Ccnd1* ([@bib17]), we hypothesized that JMJD1A/JMJD1B-mediated H3K9 demethylation will upregulate the transcription of *Oct3/4* and *Ccnd1*. To evaluate this hypothesis, we examined the H3K9 methylation levels of *Oct3/4* and *Ccnd1* promoters and the mRNA expression levels of *Oct3/4* and *Ccnd1* in JMJD1A/JMJD1B-depleted ESCs. As shown in [Figures 5](#fig5){ref-type="fig"}E and 5F, JMJD1A/JMJD1B depletion increased the levels of H3K9me2 at *Oct3/4* and *Ccnd1* and decreased their transcription. To further confirm the effect of JMJD1-mediated H3K9 demethylation on *Oct3/4* and *Ccnd1* regulation, we examined the enrichment of JMJD1A and JMJD1B at *Oct3/4* and *Ccnd1* loci. ChIP analysis revealed that JMJD1A was significantly enriched at the promoter regions of *Oct3/4* and *Ccnd1* in ESCs ([Figure 5](#fig5){ref-type="fig"}G). ChIP analysis of *1b*^+/Flag−KI^ ESCs demonstrated that endogenous JMJD1B was significantly enriched at the promoter regions of *Oct3/4* and *Ccnd1* ([Figure 5](#fig5){ref-type="fig"}H). Taking these results together, we conclude that JMJD1A and JMJD1B catalyze H3K9 demethylation of *Oct3/4* and *Ccnd1* gene promoters, thereby activating their transcription.

Collaborative Roles of JMJD1A/JMJD1B Demethylases and G9A Methyltransferase for Tuning the H3K9 Methylation Levels and Regulation of ESC Function {#sec2.6}
-------------------------------------------------------------------------------------------------------------------------------------------------

The data presented here suggest that the excess accumulation of H3K9 methylation might cause rapid cell death and perturbed gene expression in JMJD1A/JMJD1B-depleted cells. To verify this possibility, we tried to identify the enzymes responsible for H3K9 overmethylation in JMJD1A/JMJD1B-depleted cells. We have previously demonstrated that GLP/G9A methyltransferase complex catalyzes H3K9 methylation in the euchromatin ([@bib18], [@bib19]). Assuming the strong candidate of this complex for euchromatic H3K9 overmethylation in the JMJD1A/JMJD1B-depleted cells, we introduced G9A-conditional alleles into the Quad-cKO cell line. Consequently, Hexa-cKO cells, in which JMJD1A, JMJD1B, and G9A could be inducibly depleted, were obtained ([Figure 6](#fig6){ref-type="fig"}A). Surprisingly, the Hexa-cKO cells demonstrated normal growth when they were cultured in the presence of 4OHT ([Figure 6](#fig6){ref-type="fig"}B), suggesting that G9A depletion restored the growth potential of JMJD1A/JMJD1B-depleted ESCs. As expected by this finding, ESC lines lacking JMJD1A, JMJD1B, and G9A (named as JGTKO) were easily established from a pool of Hexa-cKO cells cultured with 4OHT, confirming that the triple-KO ESCs have normal growth potential ([Figures 6](#fig6){ref-type="fig"}A and 6C). Next, H3K9 methylation levels of the JGTKO lines were assessed by immunoblot analysis ([Figures 6](#fig6){ref-type="fig"}D--6F). The additional *G9a* mutation induced drastic reductions in H3K9me2 and H3K9me3 levels in ESCs with JMJD1A/JMJD1B-deficient background ([Figures 6](#fig6){ref-type="fig"}E and 6F). Taken together, we conclude that G9A is a bona fide enzyme responsible for the H3K9 overmethylation in JMJD1A/JMJD1B-depleted ESCs and that G9A-mediated H3K9 overmethylation is the cause of cell death in JMJD1A/JMJD1B-depleted ESCs.Figure 6Collaborative Roles of JMJD1A/JMJD1B Demethylases and G9A Methyltransferase for Tuning the H3K9 Methylation Levels and Regulating ESC Function(A) Genotypes of the established ESC line. Hexa-cKO cell line carries alleles for the null mutation of *Jmjd1a*, the conditional mutation of *Jmjd1b*, and the conditional mutation of *G9a*. ESC lines lacking JMJD1A, JMJD1B, and G9A (named JGTKO-1 and JGTKO-7) were established by cloning from a pool of Hexa-cKO cells cultured in the presence of 4OHT.(B) Growth curve of Hexa-cKO cell line in the presence or absence of 4OHT.(C) JMJD1A, JMJD1B, and G9A proteins were absent in JGTKO-1 and JGTKO-7 ESC lines. Whole-cell extracts were fractionated by SDS-PAGE, and then subjected to immunoblot analysis with the indicated antibodies.(D--F) *G9a* mutation rescues the H3K9 overmethylation phenotype of JMJD1A/JMJD1B-double-depleted cells. H3K9me2 and H3K9me3 levels in the indicated cell lines were examined by immunoblot analysis (D) and summarized (E and F, respectively). The intensities of H3K9me signals of Quad-cKO + 4OHT were defined as 1. Data are presented as means ± SD from n = 3 independent experiments. ^∗∗∗^p \< 0.001 (Student\'s t test).(G) Distribution profiles of H3K9me2 of JGTKO cells along chromosome 11. The top panel shows the number of mm10 RefSeq genes smoothed over 500 kb. The middle panels represent the ratios of normalized ChIP/input of ESCs of the indicated genotypes, including wild-type and JMJD1A/JMJD1B-depleted cells. The ratio of ChIP/input \>1.6 is shown in orange.(H) Correlation between gene density and decreased H3K9me2 levels due to *G9a* mutation in JMJD1A/JMJD1B-depleted cells. The x and y axes indicate the number of mm10 RefSeq genes and the quotient of ChIP/input of Quad-cKO+4OHT divided by ChIP/input of JGTKO cells, respectively, smoothed over 500 kb. Dashed lines represent regression curves.

To investigate how *G9a* mutation altered the genome-wide distribution of H3K9 methylation, we examined the H3K9me2 distribution profile of JGTKO cells by ChIP-seq analysis ([Figure 6](#fig6){ref-type="fig"}G). Notably, less than half the amount of input DNA was immunoprecipitated with anti-H3K9me2 antibody from JGTKO cell nuclei than from JMJD1A/JMJD1B-depleted cell nuclei, indicating that G9A might actually contribute to H3K9 di-methylation in JMJD1A/JMJD1B-depleted cells ([Figure S4](#mmc1){ref-type="supplementary-material"}). The distribution profile of H3K9me2 on chromosome 11 of JGTKO cells is shown in [Figure 6](#fig6){ref-type="fig"}G. We found that *G9a* mutation resulted in decreased H3K9me2 levels throughout chromosome 11, confirming that G9A substantially contributes to H3K9 di-methylation in JMJD1A/JMJD1B-depleted cells. To address the target preference of G9A-mediated H3K9 methylation, the relationship between the decreased H3K9me2 levels due to *G9a* mutation in JMJD1A/JMJD1-depleted cells and gene densities of all chromosomes was statistically evaluated as in [Figure 4](#fig4){ref-type="fig"}B. No significant differences were detected in G9A-mediated H3K9 methylation levels between the gene-poor and gene-dense regions ([Figure 6](#fig6){ref-type="fig"}H). These data suggest that the target preference of G9A-mediated H3K9 methylation is less strict than that of JMJD1A and JMJD1B-mediated H3K9 demethylation, which preferentially targets gene-dense regions ([Figure 4](#fig4){ref-type="fig"}B).

*G9a* Mutation Rescues JMJD1A/JMJD1B-Depletion-Induced Transcriptional Downregulation {#sec2.7}
-------------------------------------------------------------------------------------

To address the question of whether *G9a* mutation also restores gene expression profiles in JMJD1A/JMJD1B-depleted cells, we examined the expression levels of 204 genes in JGTKO cells that were downregulated due to JMJD1A/JMJD1B depletion. As shown in [Figure 7](#fig7){ref-type="fig"}A, *G9a* mutation remarkably restored the expression levels of those genes. To investigate the roles of JMJD1A/JMJD1B-mediated H3K9 demethylation and G9A-mediated H3K9 methylation in transcription regulation at single-gene level, we examined H3K9 methylation and mRNA expression of *Oct3/4* and *Ccnd1* in the serial mutant ESC lines ([Figures 7](#fig7){ref-type="fig"}B and 7C, respectively). ChIP analyses demonstrated that the elevated H3K9me2 levels were rescued by the introduction of *G9a* mutation ([Figure 7](#fig7){ref-type="fig"}B), strongly suggesting that H3K9me2 levels of *Oct3/4* and *Ccnd1* were regulated by both JMJD1A/JMJD1B-mediated H3K9 demethylation and G9A-mediated H3K9 methylation. mRNA analyses indicated typical inverse correlations between the H3K9me2 levels and the expression levels of *Oct3/4* and *Ccnd1*; the decreased mRNA expression levels of *Oct3/4* and *Ccnd1* were rescued by *G9a* mutation ([Figures 7](#fig7){ref-type="fig"}B and 7C). Thus, we conclude that the antagonistic activities between JMJD1A/JMJD1B and G9A collaboratively contribute to the tuning of H3K9 methylation levels in *Oct3/4* and *Ccnd1*. We summarize the function of JMJD1A/JMJD1B in the maintenance of ESCs as follows: H3K9 demethylases JMJD1A and JMJD1B ensure cell viability and transcriptional accuracy by removing the H3K9 methylation marks deposited by G9A in the gene-dense euchromatin ([Figure 7](#fig7){ref-type="fig"}D).Figure 7*G9a* Mutation Rescues JMJD1A/JMJD1B-Depletion-Induced Transcriptional Downregulation(A) Comparison of average expression levels of 204 genes that were downregulated by JMJD1A/JMJD1B depletion between the mutant ESCs. Introduction of *G9a* mutation in JMJD1A/JMJD1B-deficient background significantly restored the expression levels of those genes. ^∗∗∗^p \< 0.001 (Student\'s t test).(B and C) JMJD1A/JMJD1B and G9A antagonistically tune the H3K9 methylation levels of *Oct3/4* and *Ccnd1* to ensure accurate transcription. (B) The H3K9me2 levels in the promoter regions of *Oct3/4* (left) and *Ccnd1* (right) were examined by performing ChIP-qPCR analyses. Increased H3K9me2 levels in these genes in JMJD1A/JMJD1B-double-depleted cells were rescued by G9A depletion. (C) The expression levels of *Oct3/4* (left) and *Ccnd1* (right) were examined by RT-qPCR analyses. Reduced expression levels of these genes in JMJD1A/JMJD1B-double-depleted cells were rescued by G9A depletion. mRNA expression levels of wild-type cells were defined as 1. For (B) and (C), data are presented as means ± SD. n = 3 independent experiments. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (Student\'s t test).(D) Schematic representation of the roles of JMJD1A/JMJD1B in ESCs. JMJD1A/JMJD1B ensure cell viability and transcriptional accuracy by antagonizing G9a-mediated H3K9 overmethylation in gene-rich euchromatin in ESCs. In wild-type ESCs, JMJD1A/JMJD1B preferentially remove H3K9 methylation marks from gene-rich euchromatin. The compound loss of JMJD1A/JMJD1B results in G9a-mediated H3K9 overmethylation in euchromatin, thereby inducing cell death and impaired gene expression.

As shown in [Figure 6](#fig6){ref-type="fig"}B, JMJD1A/JMJD1B- and G9A-triple-KO cells clearly re-acquired growth potential, indicating that ESCs can survive in the absence of JMJD1A/JMJD1B- and G9A-mediated H3K9 methylation tuning. To address the possible importance of JMJD1A/JMJD1B- and G9A-mediated H3K9 methylation tuning for differentiation of ESCs, we cultured the JMJD1A/JMJD1B/G9A-triple-deficient JGTKO-1 line under differentiating condition without leukemia inhibitory factor. As shown in [Figure S6](#mmc1){ref-type="supplementary-material"}, the JGTKO cell line immediately lost growth potential in the differentiating condition. We further examined the kinetics of mRNA expression of several pluripotency-associated genes ([Figure S6](#mmc1){ref-type="supplementary-material"}). In wild-type cells, pluripotency-associated genes were downregulated concomitantly with differentiation. In contrast, some pluripotency-associated genes were not downregulated in the JGTKO line in the differentiating condition ([Figure S6](#mmc1){ref-type="supplementary-material"}). These results indicate that collaborative H3K9 methylation tuning by JMJD1A/JMJD1B and G9A plays an indispensable role in the suppression of pluripotency-associated genes when ESCs undergo differentiation.

Discussion {#sec3}
==========

We previously demonstrated that JMJD1A and JMJD1B have intrinsic enzymatic activities for H3K9 demethylation ([@bib11]). Here, we report the functional overlap of JMJD1A and JMJD1B in early embryogenesis and ESC maintenance in mice. As expected, JMJD1A and JMJD1B are both expressed in developing embryos and ESCs ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, respectively). On the other hand, *Jmjd1a* single-mutant mice display unique phenotypes, such as defects of spermiogenesis ([@bib14], [@bib16]), metabolism ([@bib7], [@bib20]), and sex determination ([@bib12]). We speculate that *Jmjd1a* is highly expressed in these tissues and therefore plays a dominant role in H3K9 demethylation. According to this notion, protein expression profiles of JMJD1A and JMJD1B are distinctive in the human tissues (<http://www.humanproteomemap.org/>).

We demonstrated that the combined depletion of JMJD1A and JMJD1B has a synergistic effect on gene expression ([Figure 5](#fig5){ref-type="fig"}). It is plausible that the growth defect phenotype of JMJD1A/JMJD1B-depleted ESCs is attributed to distorted gene expression, at least partly. Note that the GO terms for the multiple metabolic pathways downregulated by JMJD1A/JMJD1B deficiency include the one-carbon and amino acid biosynthetic pathways ([Figure S5](#mmc1){ref-type="supplementary-material"}). It is feasible that disorders in multiple metabolic pathways might induce the loss of ESC viability.

Mammalian cells have multiple H3K9 methyltransferases and demethylases with different product/substrate specificities and target specificities ([@bib5], [@bib10]). The antagonistic activities of H3K9 methyltransferase and demethylase are considered to contribute to the tuning of the H3K9 methylation levels, but how and which combination of methyltransferase/demethylase contributes to this regulation were still unresolved. Here, we demonstrated that JMJD1A/JMJD1B demethylases and G9A methyltransferase are involved in the tuning of the H3K9 methylation levels (summarized in [Figure 7](#fig7){ref-type="fig"}D). To the best of our knowledge, this is the first study revealing the role sharing between demethylase and methyltransferase for the correct establishment of histone methylated epigenome. In this context, G9A-mediated H3K9 methylation seems to exhibit less specificity for the target region of chromosomes ([Figure 6](#fig6){ref-type="fig"}H). According to this notion, a previous ChIP-seq analysis demonstrated that G9A is located in almost all chromosomal regions ([@bib15]). On the other hand, ChIP-seq analysis in our present study revealed that JMJD1A/JMJD1B-mediated H3K9 demethylation may preferentially target gene-dense euchromatin ([Figure 4](#fig4){ref-type="fig"}B). How JMJD1A/JMJD1B exerts target specificity toward euchromatin needs to be ascertained. Like most of the histone modification enzymes, JMJD1A and JMJD1B do not contain typical DNA recognition motifs, strongly suggesting that the target specificity of these proteins is dependent on the interaction of other proteins. JMJD1A and JMJD1B bear the signature LXXLL motif indicative of a protein-protein interaction with the nuclear receptors. It was reported that JMJD1A is recruited to androgen-receptor target genes in a hormone-dependent manner ([@bib22]). A recent study revealed that phosphorylation of JMJD1A strengthens the binding capacity to binding partner proteins, such as PPARγ ([@bib1]). However, as shown in [Figure 4](#fig4){ref-type="fig"}D, it seems likely that JMJD1A/JMJD1B-mediated H3K9 demethylation can target megabase ranges of the chromosomal region. Thus, it is also conceivable that JMJD1A/JMJD1B forms a complex with a nuclear protein, which can recognize the global chromatin structure rather than specific DNA sequences.

Unexpectedly, our results indicate that JMJD1A/JMJD1B- and G9A-mediated H3K9 methylation tuning is dispensable for the maintenance of ESCs ([Figure 6](#fig6){ref-type="fig"}B). On the other hand, this tuning machinery seems to play an indispensable role when ESCs undergo differentiation because the downregulation of pluripotency-associated genes was compromised in the JGTKO line when cultured in the differentiating condition ([Figure S6](#mmc1){ref-type="supplementary-material"}). A previous study demonstrated that the forced expression of protein kinase A in ESCs induces cellular differentiation concomitantly with G9A-mediated H3K9 methylation of the *Oct3/4* locus ([@bib21]). We demonstrated that the *Oct3/4* locus undergoes not only G9A-mediated H3K9 methylation but also JMJD1A/JMJD1B-mediated H3K9 demethylation to ensure correct expression levels ([Figures 7](#fig7){ref-type="fig"}B and 7C). It is plausible that the collaboration of JMJD1A/JMJD1B-mediated H3K9 demethylation and G9A-mediated H3K9 methylation may be essentially required for the rearrangement of H3K9 methylated epigenome upon differentiation. Based on the result that *G9a* mutation rescued compromised gene expression due to JMJD1A/JMJD1B depletion ([Figure 7](#fig7){ref-type="fig"}A), we speculate that the fine-tuning of H3K9 methylation by JMJD1 and G9A may contribute to transcriptional regulation of not only *Oct3/4* but also other genes important for ESC function.

It has been demonstrated that lysine methyltransferases and demethylases regulate methylation dynamics not only for histones but also for non-histone proteins ([@bib6]). Most recently, it was demonstrated that the GLP/G9A complex methylates lysine residues within the TARK motif of DNA Ligase 1, which is similar to the H3K9 methylation within the TARK motif of histone H3 ([@bib4]). To the best of our knowledge, the contribution of JMJD1A and JMJD1B toward the demethylation of non-histone protein substrates has not been reported. The possibility that JMJD1A/JMJD1B and G9A regulate methylation of non-histone proteins warrants further investigation.

Note that the levels of H3K9me2 and H3K9me3 in the triple-KO cells were slightly but significantly higher than those in the *G9a*-deficient cells ([Figures 6](#fig6){ref-type="fig"}D--6F). These data indicate that JMJD1A and JMJD1B demethylate the H3K9me2 and H3K9me3 marks deposited by H3K9 methyltransferase(s) other than G9A. We propose that the balance in H3K9 methylation levels is maintained in a highly orchestrated manner, governed by multiple enzymes for methylation and demethylation.

Experimental Procedures {#sec4}
=======================

Generation of Mutant Mice and ESCs {#sec4.1}
----------------------------------

Serial knockin targeting vectors were constructed by the bacterial artificial chromosome recombineering technique ([@bib2]) and then introduced into the ESC line TT2. Detailed information for the generation of mutant mice and ESCs is described in [Supplemental Information](#app3){ref-type="sec"}. All animal experiments were performed under the animal ethical guidelines of Tokushima University (experiment number 14,108, approved by The Ethics Committee of Tokushima University for Animal Research) and Kyoto University (experiment number A12-6-2, approved by Animal Experimentation Committee of Kyoto University).
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